S 141
117th Congress
Senate
Taxation
Business expenses
Income tax deductions
Marketing and advertising
Prescription drugs
End Taxpayer Subsidies for Drug Ads Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 28, 2021
Read twice and referred to the Committee on Finance.
Jan 28, 2021
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
End Taxpayer Subsidies for Drug Ads Act
This bill prohibits a tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs.
Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is in regard to the drug product and primarily targeted to the general public.
What's happening now
Read twice and referred to the Committee on Finance.
Related & companion bills
2
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
18
D
Murphy, Christopher
D
Schatz, Brian
D
Baldwin, Tammy
D
Bennet, Michael F.
D
Blumenthal, Richard
D
Durbin, Richard J.
D
Gillibrand, Kirsten E.
D
Hassan, Margaret Wood
D
Hirono, Mazie K.
D
Kaine, Tim
I
King, Angus S., Jr.
D
Klobuchar, Amy
D
Reed, Jack
I
Sanders, Bernard
D
Smith, Tina
D
Van Hollen, Chris
D
Warren, Elizabeth
D
Whitehouse, Sheldon
Cite this page
U.S. Congress. (2026). S. 141: End Taxpayer Subsidies for Drug Ads Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-141/
"S. 141: End Taxpayer Subsidies for Drug Ads Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-141/.
S. 141, 117th Cong. (2026), https://openamerica.io/bill/117-S-141/.
[S. 141: End Taxpayer Subsidies for Drug Ads Act](https://openamerica.io/bill/117-S-141/)